Comparative Clinical Evaluation Of Kumkumadi Ghrita Nasya And Shalparni Swaras Nasya In Ardhavbhedaka (Migraine)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Assessment will be done on the basis of subjective parameters
研究概览
简要总结
in this trial , we are selecting the patients of Ardhavbhedaka in which we will do the intervention in two groups (30 patients in each group).
In the group , we will intervene with ayurvedic procedure of nasya with Kumkumadi Ghrit Nasya for 14 days ,
whereas in other group, we will intervene with ayurvedic procedure of nasya with Shalparni Swara Nasya for 14 days .
Assessment should be done on the basis of Subjective parameters and investigations done during pre-treatment and post treatment as discussed earlier.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with classical signs & symptoms of Ardhavabhedaka (Migraine) described as per Ayurvedic and modern science.
- •Patients between the age group of 16 years to 60 years of either sex.
- •Patients in related group who are fit for Nasya Karma / Nasya yogya vyakti.
排除标准
- •Patients less than 16 years and above 60 years of age.
- •Patients who are contraindicated for Nasya Karma.
- •Patients suffering from cluster headache, tension type of headache, sinus headache, and arising due to Meningitis ,Encephalitis, and Ocular manifestations.
- •Patient suffering from any systemic diseases like diabetes mellitus, heart disease, hypertension, cancer and receiving medication which may alter the results of study.
结局指标
主要结局
Assessment will be done on the basis of subjective parameters
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
Intensity of Headache
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
Frequency of headache
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
Duration of Headache
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
Nausea
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
Vomiting
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
Vertigo
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
Aura
时间窗: Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).
次要结局
- Assessment will be done on the basis of subjective parameters(Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).)
研究者
Ananya Singh
Patanjali Ayurvigyan Evam Anusandhan Sansthan, Haridwar